Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance.

Authors: Ciebiera, Michał; Ali, Mohamed; Zgliczyńska, Magdalena; Skrzypczak, Maciej; Al-Hendy, Ayman

Published In Int J Mol Sci, (2020 Aug 01)

Abstract: Uterine fibroid (UF) is the most common benign tumor pathology of the female reproductive organs. UFs constitute the main reason for a hysterectomy and hospitalization due to gynecological conditions. UFs consist of uterine smooth muscle immersed in a large amount of extracellular matrix (ECM). Genetic studies have demonstrated that UFs are monoclonal tumors originating from the myometrial stem cells that have underwent specific molecular changes to tumor initiating stem cells which proliferate and differentiate later under the influence of steroid hormones. There is growing interest in the role of micronutrients, for example, vitamins, in UFs. This article is a comprehensive review of publications regarding the available data concerning the role of vitamins in the biology and management of UFs. In summary, the results showed that some vitamins are important in the biology and pathophysiology of UFs. For example, vitamins A and D deserve particular attention following studies of their influence on the treatment of UF tumors. Vitamins B3, C, and E have not been as widely studied as the abovementioned vitamins. However, more research could reveal their potential role in UF biology.

PubMed ID: 32752274 Exiting the NIEHS site

MeSH Terms: Female; Genetic Predisposition to Disease/genetics*; Humans; Leiomyoma/genetics; Leiomyoma/metabolism; Leiomyoma/prevention & control*; Mediator Complex/genetics*; Mutation*; Uterine Neoplasms/genetics; Uterine Neoplasms/metabolism; Uterine Neoplasms/prevention & control*; Vitamin A/metabolism; Vitamin A/therapeutic use; Vitamin D/metabolism; Vitamin D/therapeutic use; Vitamins/metabolism; Vitamins/therapeutic use*

Back
to Top